Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Endocrine orbitopathy 1998]

G Förster1, G Kahaly

  • 1Klinik und Poliklinik Innere Medizin, Schwerpunkt Endokrinologie und Stoffwechselerkrankungen, Johannes-Gutenberg-Universität Mainz.

Medizinische Klinik (Munich, Germany : 1983)
|July 15, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The fingerprint of the summer 2018 drought in Europe on ground-based atmospheric CO<sub>2</sub> measurements.

Philosophical transactions of the Royal Society of London. Series B, Biological sciences·2020
Same author

Effects of halogens on European air-quality.

Faraday discussions·2017
Same author

Microinfarcts in an older population-representative brain donor cohort (MRC CFAS): Prevalence, relation to dementia and mobility, and implications for the evaluation of cerebral Small Vessel Disease.

Neuropathology and applied neurobiology·2016
Same author

Novel method for sludge blanket measurements.

Water science and technology : a journal of the International Association on Water Pollution Research·2014
Same author

Periodontal conditions in vegetarians: a clinical study.

European journal of clinical nutrition·2013
Same author

Brain haemosiderin in older people: pathological evidence for an ischaemic origin of magnetic resonance imaging (MRI) microbleeds.

Neuropathology and applied neurobiology·2013
Same journal

[75-year old female with progressive idiopathic lung fibrosis].

Medizinische Klinik (Munich, Germany : 1983)·2011
Same journal

[Mesenterial lymphangiolipoma - a rare finding in an asymptomatic patient].

Medizinische Klinik (Munich, Germany : 1983)·2011
Same journal

[Resistant hypertension despite nine different antihypertensive drugs?].

Medizinische Klinik (Munich, Germany : 1983)·2011
Same journal

[From the design of use study to the assessment of the benefit: with or without pharmaceutical industry?].

Medizinische Klinik (Munich, Germany : 1983)·2011
Same journal

[Memorandum III "methods for health services research", Part 1 [authors: H. Pfaff, G. Glaeske, E. A. M. Neugebauer, M. Schrappe] and Part 2 [authors: E. A. M. Neugebauer, A. Icks, M. Schrappe] of the Deutsches Netzwerk Versorgungsforschung e.V.: A summary].

Medizinische Klinik (Munich, Germany : 1983)·2011
Same journal

[Pulmonary affection in advanced liver disease - hepatepulonary syndrome and portopulmonary hypertension].

Medizinische Klinik (Munich, Germany : 1983)·2011
See all related articles

Graves' disease can cause thyroid-associated ophthalmopathy, an autoimmune condition affecting the eyes. Early diagnosis and interdisciplinary management are key for effective treatment and improved outcomes.

Area of Science:

  • Ophthalmology
  • Immunology
  • Endocrinology

Context:

  • Ophthalmopathy is the most common extrathyroidal manifestation of Graves' disease.
  • This autoimmune disorder involves lymphocyte infiltration of the retrobulbar space, leading to tissue changes and extraocular muscle enlargement.
  • Inflammatory processes increase orbital pressure, causing clinical eye disease manifestations.

Purpose:

  • To summarize the understanding of thyroid-associated ophthalmopathy, its pathogenesis, and current therapeutic approaches.
  • To highlight the role of immunosuppression in managing the inflammatory stage of the disease.
  • To emphasize the need for updated therapy concepts based on new pathogenetic insights and clinical trials.

Summary:

  • Thyroid-associated ophthalmopathy results from an autoimmune response targeting retrobulbar tissues, characterized by inflammation, edema, and muscle enlargement.

Related Experiment Videos

  • Initial treatment often involves immunosuppression to mitigate inflammatory changes and improve symptoms.
  • Recent advancements in understanding pathogenesis and clinical trials have led to modified therapeutic strategies.

    • Impact:

    • Improved understanding of thyroid-associated ophthalmopathy pathogenesis.
    • Evidence supporting the efficacy of immunosuppressive therapy in the inflammatory phase.
    • Development of modified and potentially more effective treatment concepts for thyroid eye disease.